Greater time-updated vericiguat exposure was linked to less myocardial fibrosis and reduced rehospitalizations in older adults with worsening HFrEF, especially with higher GDMT-4.
Does higher vericiguat dose exposure reduce myocardial fibrosis burden in older adults with worsening heart failure with reduced ejection fraction?
Higher vericiguat exposure is associated with reduced myocardial fibrosis and fewer rehospitalizations in older adults with worsening HFrEF, particularly when combined with quadruple guideline-directed medical therapy.
Absolute Event Rate: 0% vs 0%
Greater time-updated vericiguat exposure was linked to less fibrosis and an exploratory reduction in rehospitalizations, especially with higher GDMT-4.
Ge et al. (Fri,) reported a other. Greater time-updated vericiguat exposure was linked to less myocardial fibrosis and reduced rehospitalizations in older adults with worsening HFrEF, especially with higher GDMT-4.